
Shobha Kantamneni
Examiner (ID: 1732, Phone: (571)272-2930 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1627, 1617, 1623 |
| Total Applications | 1212 |
| Issued Applications | 306 |
| Pending Applications | 120 |
| Abandoned Applications | 793 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6638819
[patent_doc_number] => 20100036001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'HEPAROSAN POLYMERS AND METHODS OF MAKING AND USING SAME FOR THE ENHANCEMENT OF THERAPEUTICS'
[patent_app_type] => utility
[patent_app_number] => 12/556324
[patent_app_country] => US
[patent_app_date] => 2009-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15897
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20100036001.pdf
[firstpage_image] =>[orig_patent_app_number] => 12556324
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/556324 | Heparosan polymers and methods of making and using same for the enhancement of therapeutics | Sep 8, 2009 | Issued |
Array
(
[id] => 6496170
[patent_doc_number] => 20100093865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'SULPHUR-LINKED COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/553054
[patent_app_country] => US
[patent_app_date] => 2009-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 108630
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093865.pdf
[firstpage_image] =>[orig_patent_app_number] => 12553054
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/553054 | SULPHUR-LINKED COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS | Sep 1, 2009 | Abandoned |
Array
(
[id] => 6376085
[patent_doc_number] => 20100076089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'ANTIMICROBIAL GEL FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/540251
[patent_app_country] => US
[patent_app_date] => 2009-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15586
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20100076089.pdf
[firstpage_image] =>[orig_patent_app_number] => 12540251
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/540251 | ANTIMICROBIAL GEL FORMULATIONS | Aug 11, 2009 | Abandoned |
Array
(
[id] => 5304210
[patent_doc_number] => 20090298862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'Methods useful for the treatment of pain, arthritic conditions or inflammation associated with a chronic condition'
[patent_app_type] => utility
[patent_app_number] => 12/315740
[patent_app_country] => US
[patent_app_date] => 2009-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 33263
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298862.pdf
[firstpage_image] =>[orig_patent_app_number] => 12315740
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/315740 | Methods useful for the treatment of pain, arthritic conditions or inflammation associated with a chronic condition | Aug 6, 2009 | Abandoned |
Array
(
[id] => 5973326
[patent_doc_number] => 20110152377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'EXTERNAL PREPARATION COMPRISING FATTY ACID SALT OR BENZOIC ACID SALT OF BASIC PHARMACOLOGICALLY ACTIVE COMPONENT, AND METHOD FOR PRODUCTION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/057188
[patent_app_country] => US
[patent_app_date] => 2009-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13669
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20110152377.pdf
[firstpage_image] =>[orig_patent_app_number] => 13057188
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/057188 | EXTERNAL PREPARATION COMPRISING FATTY ACID SALT OR BENZOIC ACID SALT OF BASIC PHARMACOLOGICALLY ACTIVE COMPONENT, AND METHOD FOR PRODUCTION THEREOF | Aug 2, 2009 | Abandoned |
Array
(
[id] => 7657342
[patent_doc_number] => 20110306611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'Transcription factor modulating compounds and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/462405
[patent_app_country] => US
[patent_app_date] => 2009-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 58053
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20110306611.pdf
[firstpage_image] =>[orig_patent_app_number] => 12462405
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/462405 | Transcription factor modulating compounds and methods of use thereof | Aug 2, 2009 | Issued |
Array
(
[id] => 6257930
[patent_doc_number] => 20100029755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'P-Glycoprotein inhibitor comprising octilonium bromide as an effective ingredient'
[patent_app_type] => utility
[patent_app_number] => 12/458673
[patent_app_country] => US
[patent_app_date] => 2009-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4996
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029755.pdf
[firstpage_image] =>[orig_patent_app_number] => 12458673
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/458673 | P-Glycoprotein inhibitor comprising octilonium bromide as an effective ingredient | Jul 19, 2009 | Abandoned |
Array
(
[id] => 5959685
[patent_doc_number] => 20110184072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'FORMULATION INTENDED TO IMPROVING THE BIOAVAILABILITY OF A HYDROPHOBIC MOLECULE'
[patent_app_type] => utility
[patent_app_number] => 13/054776
[patent_app_country] => US
[patent_app_date] => 2009-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2620
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20110184072.pdf
[firstpage_image] =>[orig_patent_app_number] => 13054776
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/054776 | FORMULATION INTENDED TO IMPROVING THE BIOAVAILABILITY OF A HYDROPHOBIC MOLECULE | Jul 15, 2009 | Abandoned |
Array
(
[id] => 6496260
[patent_doc_number] => 20100010062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'METHOD OF TREATMENT USING EPROSARTAN'
[patent_app_type] => utility
[patent_app_number] => 12/500425
[patent_app_country] => US
[patent_app_date] => 2009-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11220
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20100010062.pdf
[firstpage_image] =>[orig_patent_app_number] => 12500425
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/500425 | METHOD OF TREATMENT USING EPROSARTAN | Jul 8, 2009 | Abandoned |
Array
(
[id] => 6033352
[patent_doc_number] => 20110082161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-07
[patent_title] => 'POWDERS FOR RECONSTITUTION'
[patent_app_type] => utility
[patent_app_number] => 12/997185
[patent_app_country] => US
[patent_app_date] => 2009-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9200
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20110082161.pdf
[firstpage_image] =>[orig_patent_app_number] => 12997185
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/997185 | POWDERS FOR RECONSTITUTION | Jun 29, 2009 | Abandoned |
Array
(
[id] => 6039508
[patent_doc_number] => 20110092557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'Neuraminidase Inhibitors And Compositions And Methods Related Thereto'
[patent_app_type] => utility
[patent_app_number] => 12/490650
[patent_app_country] => US
[patent_app_date] => 2009-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8871
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20110092557.pdf
[firstpage_image] =>[orig_patent_app_number] => 12490650
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/490650 | Neuraminidase Inhibitors And Compositions And Methods Related Thereto | Jun 23, 2009 | Abandoned |
Array
(
[id] => 6048863
[patent_doc_number] => 20110207834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'HIGHLY PURIFIED POLYLACTIC ACID OR A DERIVATIVE THEREOF, A SALT OF THE SAME, AND PURIFICATION METHOD THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/126395
[patent_app_country] => US
[patent_app_date] => 2009-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5253
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20110207834.pdf
[firstpage_image] =>[orig_patent_app_number] => 13126395
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/126395 | Highly purified polylactic acid or a derivative thereof, a salt of the same, and purification method thereof | Jun 22, 2009 | Issued |
Array
(
[id] => 7490764
[patent_doc_number] => 20110237677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/997424
[patent_app_country] => US
[patent_app_date] => 2009-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5114
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20110237677.pdf
[firstpage_image] =>[orig_patent_app_number] => 12997424
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/997424 | Inhibitors | Jun 9, 2009 | Abandoned |
Array
(
[id] => 5987447
[patent_doc_number] => 20110098366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'Pharmaceutical Preparation in Containers that are Pervious to Water Vapor and Have Improved Stability'
[patent_app_type] => utility
[patent_app_number] => 12/997909
[patent_app_country] => US
[patent_app_date] => 2009-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1981
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098366.pdf
[firstpage_image] =>[orig_patent_app_number] => 12997909
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/997909 | Pharmaceutical Preparation in Containers that are Pervious to Water Vapor and Have Improved Stability | May 29, 2009 | Abandoned |
Array
(
[id] => 9850346
[patent_doc_number] => 08952075
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-10
[patent_title] => 'Bioactive polymeric liquid formulations of absorbable, segmented aliphatic polyurethane compositions'
[patent_app_type] => utility
[patent_app_number] => 12/454774
[patent_app_country] => US
[patent_app_date] => 2009-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3500
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12454774
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/454774 | Bioactive polymeric liquid formulations of absorbable, segmented aliphatic polyurethane compositions | May 21, 2009 | Issued |
Array
(
[id] => 5514168
[patent_doc_number] => 20090214474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development'
[patent_app_type] => utility
[patent_app_number] => 12/387239
[patent_app_country] => US
[patent_app_date] => 2009-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58312
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20090214474.pdf
[firstpage_image] =>[orig_patent_app_number] => 12387239
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/387239 | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development | Apr 29, 2009 | Abandoned |
Array
(
[id] => 8174226
[patent_doc_number] => 20120108823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'ANTI-FRANCISELLA AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/428035
[patent_app_country] => US
[patent_app_date] => 2009-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9295
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20120108823.pdf
[firstpage_image] =>[orig_patent_app_number] => 12428035
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/428035 | ANTI-FRANCISELLA AGENTS | Apr 21, 2009 | Abandoned |
Array
(
[id] => 5302946
[patent_doc_number] => 20090297598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'THERAPEUTIC COMBINATION'
[patent_app_type] => utility
[patent_app_number] => 12/427420
[patent_app_country] => US
[patent_app_date] => 2009-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11286
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20090297598.pdf
[firstpage_image] =>[orig_patent_app_number] => 12427420
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/427420 | THERAPEUTIC COMBINATION | Apr 20, 2009 | Abandoned |
Array
(
[id] => 10830847
[patent_doc_number] => 08859009
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-14
[patent_title] => 'Method of fixing antibacterial agent and article obtained by the method'
[patent_app_type] => utility
[patent_app_number] => 12/736794
[patent_app_country] => US
[patent_app_date] => 2009-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 9147
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12736794
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/736794 | Method of fixing antibacterial agent and article obtained by the method | Apr 20, 2009 | Issued |
Array
(
[id] => 5570421
[patent_doc_number] => 20090253799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'DIVALENT HYDRAZIDE COMPOUND CONJUGATES FOR INHIBITING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR'
[patent_app_type] => utility
[patent_app_number] => 12/418147
[patent_app_country] => US
[patent_app_date] => 2009-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 31139
[patent_no_of_claims] => 87
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20090253799.pdf
[firstpage_image] =>[orig_patent_app_number] => 12418147
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/418147 | DIVALENT HYDRAZIDE COMPOUND CONJUGATES FOR INHIBITING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Apr 2, 2009 | Abandoned |